- 3.9Impact Factor
- 6.8CiteScore
- 18 daysTime to First Decision
10th Anniversary of Biomedicines—Novel Targets for Cranial Tumors
This special issue belongs to the section “Neurobiology and Clinical Neuroscience“.
Special Issue Information
Dear Colleagues,
Intracranial tumors may arise from the brain or other structures, such as the meninges, cranial nerves, and pituitary gland. The peculiarity of these tumors is that histologically benign neoplasms can also be life threatening, due to the non-expandability of the intracranial system.
The treatment options for intracranial tumors have not significantly changed over the last 20 years; surgery (from biopsy to total resection) still represents the primary option for both benign and malign neoplasms, with the exception of some pituitary adenomas. Despite advances in technology and knowledge, prognosis has not dramatically changed either.
The identification of novel potential targets for therapy and diagnosis is therefore strongly needed.
This Special Issue aims to collect original papers demonstrating possible novel targets for diagnosing or treating intracranial tumors, including, but not limited to, gliomas, schwannomas, meningiomas, pituitary adenomas, and metastases.
Prof. Dr. Pasquale De Bonis
Prof. Dr. Gianluigi Zona
Dr. Veronica Tisato
Prof. Dr. Tullio Florio
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- intracranial tumor
- pituitary adenoma
- biomarkers
- targeted therapy
- novel targets
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Related Special Issues
- Biomedicines: 10th AnniversaryinBiomedicines (46 articles)

